Organization | Hualan Biological Engineering, Inc.

Hualan Biological Engineering, Inc. Report issue

For profit Phase 3 Phase 4

Founded: Chongqing China (1992)

Status: No NME R&D (1992)

Organization Overview

First Clinical Trial

2006

NCT01661725

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2011

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (1)

inactivated influenza vaccine (4 trials)

Drugs in Phase 3 Trials (2)

Bivalent group A and C meningococcal vaccine (Menomune-A/C) (1 trial)

quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Influenza, Human (Phase 4)

Meningitis (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 3